The Parkinson’s Disease Death Rate: Carbidopa and Vitamin B6 [Expression of Concern]
Hinz M, Stein A, Cole T. Clin Pharmacol Adv Appl. 2014;6:161–169. The Editor-in-Chief and Publisher of Clinical Pharmacology: Advances and Applications wish to issue an Expression of Concern for the published article. Concerns have been raised regarding the alleg...
Guardado en:
Autores principales: | Hinz M, Stein A, Cole T |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/ff6f8e06fd324e2fafbb279707c4d5b3 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
The Parkinson’s Disease Death Rate: Carbidopa and Vitamin B6 [Retraction]
por: Hinz M, et al.
Publicado: (2021) -
Parkinson’s Disease: Carbidopa, Nausea, and Dyskinesia [Expression of Concern]
por: Hinz M, et al.
Publicado: (2020) -
Parkinson’s Disease: Carbidopa, Nausea, and Dyskinesia [Retraction]
por: Hinz M, et al.
Publicado: (2021) -
The Parkinson's disease death rate: carbidopa and vitamin B6
por: Hinz M, et al.
Publicado: (2014) -
Parkinson’s Disease-Associated Melanin Steal [Expression of Concern]
por: Hinz M, et al.
Publicado: (2020)